Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$RXRX stock fell 10% this week. Here's what we see in our data.

None

$RXRX stock fell 10% this week, according to our price data from Polygon.

It has been the 44th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.

Here is what we see in our data on $RXRX (you can track the company live on Quiver's $RXRX stock page):

$RXRX Insider Trading Activity

RXRX Insider Trades

$RXRX insiders have traded $RXRX stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.

Here’s a breakdown of recent trading of $RXRX stock by insiders over the last 6 months:

  • BLAKE BORGESON has made 0 purchases and 4 sales selling 830,000 shares for an estimated $3,432,800.
  • CHRISTOPHER GIBSON has made 0 purchases and 11 sales selling 560,000 shares for an estimated $2,696,000.
  • NAJAT KHAN (CEO and President) has made 0 purchases and 2 sales selling 152,701 shares for an estimated $643,251.
  • BEN R TAYLOR (Chief Financial Officer) has made 0 purchases and 3 sales selling 42,765 shares for an estimated $157,703.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RXRX Hedge Fund Activity

We have seen 185 institutional investors add shares of $RXRX stock to their portfolio, and 177 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RXRX Analyst Ratings

Wall Street analysts have issued reports on $RXRX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • JP Morgan issued a "Overweight" rating on 12/17/2025

To track analyst ratings and price targets for $RXRX, check out Quiver Quantitative's $RXRX forecast page.

$RXRX Price Targets

Multiple analysts have issued price targets for $RXRX recently. We have seen 3 analysts offer price targets for $RXRX in the last 6 months, with a median target of $8.0.

Here are some recent targets:

  • Michael Ryskin from B of A Securities set a target price of $6.0 on 02/26/2026
  • Gil Blum from Needham set a target price of $8.0 on 02/26/2026
  • Eric Joseph from JP Morgan set a target price of $11.0 on 12/17/2025

You can track data on $RXRX on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles